Gadolinium-Based MR Contrast Agents and Nephrogenic Systemic Fibrosis
Radiology 242:647-649, Kuo,P.H.,et al, 2007
Facial Weakness in a Haemodialysis Patient
Lancet 369:714, Papadakis,M.,et al, 2007
Secondary Hyperkalaemic Paralysis
JNNP 64:249-252, Evers,S.,et al, 1998
Neurocognitive Effects of Aluminum
Arch Neurol 49:1021-1026, Bolla,K.I.,et al, 1992
Disturbance of Cerebral Function by Aluminium in Haemodialysis Patients without Overt Aluminium Toxicity
Lancet 2:7-12, Altmann,P.,et al, 1989
Progressive Dialysis Encephalopathy
Ann Neurol 4:199-204, Lederman,R.J.,et al, 1978
Persistence of Gadolinium in CSF: A Diagnostic Pitfall in Patients with End-stage Renal Disease
AJNR 22:1357-1361, Rai,A.T. &Hogg,J.P., 2001
Neurologic Disorders in Renal Failure (1st of Two Parts)
NEJM 294:143, Raskin,N.H.,et al, 1976